...
首页> 外文期刊>Journal of drug delivery science and technology >Preparation and physicochemical characterization of the azithromycin-Eudragit RS100 nanobeads and nanofibers using electrospinning method
【24h】

Preparation and physicochemical characterization of the azithromycin-Eudragit RS100 nanobeads and nanofibers using electrospinning method

机译:静电纺丝法制备二十霉素-Eudragit RS100纳米型和纳米纤维的制备和理化特征

获取原文
获取原文并翻译 | 示例
           

摘要

Azithromycin, a macrolide antibiotic, is used to eradicate the infections of the ears, lungs, sinuses, throat, skin, and reproductive organs. So therefore, taking into consideration that the nanomedicines, may confer capability for prolonged and effective delivery of the drugs into the infected tissues and organs, the aim of the present study was to prepare azithromycin-Eudragit RS100 nanoparticles. The azithromycin-Eudragit RS100 nanobeads and nanofibers with the different drug:polymer ratios and the various solution concentrations were prepared using electrospinning technique. The physicochemical characteristics of the nanoparticles and nanofibers were evaluated using scanning electron microscopy (SEM), differential scanning calorimetty (DSC), X-ray powder diffraction (XRPD) and Fourier transform infrared spectroscopy (FT-IR). Drug release profiles were also compared by the use of three model-independent parameters i.e., t(50%) (the time at which 50 % of drug released), Q(15min) and Q(30min) (percent drug dissolved within 15 and 30 min. respectively). Increasing the dropped solution concentration resulted in more nanofibers and less nanobeads production with the particles size ranged from 100-500 um. DSC and XRPD studies indicated that the drug crystallinity was notably reduced. FI-IR analysis revealed no chemical interaction during the preparation process. Nanoformulations exhibited biphasic release profiles with higher release rates than pure drug. According of these findings, AZI-Eudragit RS100 nanofibers and nanobeads with improved physicochemical characteristics is possible to be formulated through optimizing the preparation parameters. Simplicity of the process on the other hand makes it an excellent choice for being scaled up.
机译:阿奇霉素,一种大环内酯抗生素,用于消除耳朵,肺,鼻窦,喉咙,皮肤和生殖器官的感染。因此,考虑到纳米胺,可以赋予药物延长和有效地将药物递送到感染的组织和器官中的能力,目前研究的目的是制备阿奇霉素 - Eudragit RS100纳米颗粒。使用静电纺丝技术制备二十霉素 - eudragit RS100纳米甲特和纳米纤维和纳米纤维和具有不同药物的纳米纤维和各种溶液浓度。使用扫描电子显微镜(SEM),差示扫描量热(DSC),X射线粉末衍射(XRPD)和傅里叶变换红外光谱(FT-IR)评估纳米颗粒和纳米纤维的物理化学特性。通过使用三种型号无关的参数,即T(50%)(50%)(50%的药物释放的时间),Q(15min)和Q(30min)(溶解在15内的药物百分比和30分钟。分别)。增加滴液浓度导致更多的纳米纤维和较少的纳米珠,颗粒尺寸的产生范围为100-500μm。 DSC和XRPD研究表明,药物结晶度显着降低。 FI-IR分析显示在制备过程中没有化学相互作用。纳米族种质表现出具有比纯药物更高的释放率的双相释放曲线。根据这些发现,可以通过优化制备参数来配制Azi-Eudragit RS100纳米纤维和具有改善的物理化学特性的纳米孔。另一方面,这一过程的简单性使其成为缩放的绝佳选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号